These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 21596487)
1. New breast cancer recursive partitioning analysis prognostic index in patients with newly diagnosed brain metastases. Niwińska A; Murawska M Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2065-71. PubMed ID: 21596487 [TBL] [Abstract][Full Text] [Related]
2. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Nieder C; Andratschke N; Grosu AL; Molls M Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980 [TBL] [Abstract][Full Text] [Related]
3. Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score. Le Scodan R; Massard C; Mouret-Fourme E; Guinebretierre JM; Cohen-Solal C; De Lalande B; Moisson P; Breton-Callu C; Gardner M; Goupil A; Renody N; Floiras JL; Labib A Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):839-45. PubMed ID: 17544592 [TBL] [Abstract][Full Text] [Related]
4. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems. Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108 [TBL] [Abstract][Full Text] [Related]
5. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Videtic GM; Adelstein DJ; Mekhail TM; Rice TW; Stevens GH; Lee SY; Suh JH Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):240-3. PubMed ID: 17056192 [TBL] [Abstract][Full Text] [Related]
6. Validity of three recently proposed prognostic grading indexes for breast cancer patients with radiosurgically treated brain metastases. Yamamoto M; Kawabe T; Higuchi Y; Sato Y; Barfod BE; Kasuya H; Urakawa Y Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1110-5. PubMed ID: 22516807 [TBL] [Abstract][Full Text] [Related]
7. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors. Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409 [TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909 [TBL] [Abstract][Full Text] [Related]
10. Gamma Knife radiosurgery for brain metastases from primary breast cancer. Kased N; Binder DK; McDermott MW; Nakamura JL; Huang K; Berger MS; Wara WM; Sneed PK Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1132-40. PubMed ID: 19345514 [TBL] [Abstract][Full Text] [Related]
11. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP). Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339 [TBL] [Abstract][Full Text] [Related]
12. Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. Rades D; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE Cancer; 2007 Nov; 110(10):2285-92. PubMed ID: 17922523 [TBL] [Abstract][Full Text] [Related]
13. Linac radiosurgery versus whole brain radiotherapy for brain metastases. A survival comparison based on the RTOG recursive partitioning analysis. Kocher M; Maarouf M; Bendel M; Voges J; Müller RP; Sturm V Strahlenther Onkol; 2004 May; 180(5):263-7. PubMed ID: 15127155 [TBL] [Abstract][Full Text] [Related]
14. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Paek SH; Audu PB; Sperling MR; Cho J; Andrews DW Neurosurgery; 2005 May; 56(5):1021-34; discussion 1021-34. PubMed ID: 15854250 [TBL] [Abstract][Full Text] [Related]
15. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis. Kepka L; Cieslak E; Bujko K; Fijuth J; Wierzchowski M Acta Oncol; 2005; 44(4):389-98. PubMed ID: 16120548 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in patients with brain metastases. Lagerwaard FJ; Levendag PC Forum (Genova); 2001; 11(1):27-46. PubMed ID: 11734862 [TBL] [Abstract][Full Text] [Related]
17. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases. Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520 [TBL] [Abstract][Full Text] [Related]
18. Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases. Xu Z; Schlesinger D; Toulmin S; Rich T; Sheehan J Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):612-8. PubMed ID: 22436795 [TBL] [Abstract][Full Text] [Related]
19. Subclassification of recursive partitioning analysis Class II patients with brain metastases treated radiosurgically. Yamamoto M; Sato Y; Serizawa T; Kawabe T; Higuchi Y; Nagano O; Barfod BE; Ono J; Kasuya H; Urakawa Y Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1399-405. PubMed ID: 22209155 [TBL] [Abstract][Full Text] [Related]
20. Outcome of whole-brain irradiation for breast cancer patients. Johansen R; Westin AA; Bofin AM; Lundgren S Acta Oncol; 2008; 47(2):261-6. PubMed ID: 17882559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]